课题基金 / 基金详情

lncRNA-MIR99AHG与PTBP1相互作用调控TKS5的选择性剪接促进结直肠癌细胞侵袭性伪足形成的分子机制研究

批准号:
82073197
项目类别:
面上项目
资助金额:
55.0 万元
负责人:
赵晓迪
学科分类:
肿瘤复发与转移
结题年份:
2024
批准年份:
2020
项目状态:
已结题
项目参与者:
赵晓迪

项目摘要

结项摘要

赵晓迪的其他基金

相似基金

相关文献

中文摘要
侵袭性伪足在肿瘤转移早期发挥重要作用,但调控机制尚不清楚。申请人通过比对高低转移潜能的结直肠癌细胞系的lncRNA表达谱,发现lncRNA分子MIR99AHG在高转移细胞和患者转移灶中显著升高,过表达MIR99AHG能促进转移和侵袭性伪足形成,并改变伪足关键效应分子TKS5不同剪接异构体的组成性表达,这一效应与MIR99AHG的相互作用分子即选择性剪接调控因子PTBP1相关,高度提示MIR99AHG可能通过PTBP1调控TKS5的选择性剪接,从而促进侵袭性伪足形成和肿瘤转移。本项目拟通过临床标本和队列数据,明确MIR99AHG在结直肠癌的表达模式;通过体内外功能实验,明确MIR99AHG在结直肠癌转移中的生物学功能;通过分子间相互作用研究,阐明MIR99AHG通过PTBP1调控TKS5选择性剪接的作用机制。本项目将揭示非编码RNA调控侵袭性伪足的新机制,为结直肠癌转移的临床诊疗提供新策略。
英文摘要
The formation of invadopodia by cancer cells plays an important role in the early stage of metastasis. However, the underlying regulatory mechanisms remain unclear. By comparing the lncRNA expression profiles between a pair of colorectal cancer cell lines with high and low metastatic potential, we found that MIR99AHG was significantly increased in high metastatic cancer cells and tissues from patients. Overexpression of MIR99AHG could significantly promote cell migration and invasion. MIR99AHG could interact with PTBP1, which is an important regulator of alternative splicing, and change the isoform expression ratio of the key effector molecule TKS5 of invadopodia. Our results highly suggest that MIR99AHG regulates the alternative splicing of TKS5 through PTBP1, affects the formation of invadopodia and promotes metastasis. This project intends to clarify the expression pattern of MIR99AHG in colorectal cancer through clinical specimens and cohort data, and to evaluate its clinical usages as a predictor and diagnostic biomarker in metastasis. Through in vivo and in vitro functional experiments, the biological functions of MIR99AHG in colorectal cancer will be determined. Through study of the interaction between molecules, the mechanisms of MIR99AHG in promoting the alternative splicing of TKS5 through PTBP1 will be elucidated. This project will deepen our understanding of lncRNA regulation in invadopodia formation and metastasis, and help to provide new strategies for the diagnosis and treatment of metastatic colorectal cancer.
结直肠癌是我国高发的恶性肿瘤之一,转移可导致结直肠癌患者的不良预后。因此,针对肿瘤转移的实验研究可指导临床诊治方法的改进。肿瘤细胞形成侵袭性伪足是转移发生的关键分子事件,侵袭性伪足形成过程中也包括多种分子表达、修饰和相互作用的动态调控。项目负责人通过比对高低转移潜能的结直肠癌细胞系的lncRNA表达谱,发现lncRNA分子MIR99AHG在高转移细胞和患者转移 灶中显著升高,过表达MIR99AHG能促进转移和侵袭性伪足形成,并改变伪足关键效应分子SMARCA1 不同剪接异构体的组成性表达,这一效应与MIR99AHG的相互作用分子即选择性剪接调控因子PT BP1相关,高度提示MIR99AHG可能通过PTBP1调控SMARCA1的选择性剪接,从而促进侵袭性伪足形成 和肿瘤转移。通过执行本项目,课题组明确了MIR99AHG在结直肠癌细胞和转移灶中高表达,且与结直肠癌患者的不良预后相关;阐明了MIR99AHG及其相互作用分⼦PTBP1促进结直肠癌细胞的迁移、侵袭和转移的功能;揭示了MIR99AHG和PTBP1协同调控SMARCA1 pre-mRNA的选择性剪接,促进SMARCA1 exon 13 的保留,调节结直肠癌细胞的迁移、侵袭和侵袭性伪足形成,促进结直肠癌转移的分子机制。本研究通过体内外功能实验,明确了SMARCA1亚型转换对结直肠癌转移的调控作用,并通过RNA-RNA,RNA-蛋白分子间相互作用研究深刻揭示了MIR99AHG/PTBP1/SMARCA1调控侵袭性伪足的分子机制。研究结果深化了对肿瘤转移过程的认识和理解,可为晚期CRC的临床决策和新药研发提供理论基础和明确的作用靶点。
LTBP4缺失诱导MRC1/CD44双阳性巨噬细胞新亚群调节基质重塑与免疫逃逸促进结直肠癌转移的机制研究
miR-7受长链非编码RNA FENDRR调控介导胃癌多药耐药的功能与机制研究
国内基金
海外基金